Treatment Outcomes Stratified by Baseline Immunological Status Among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited Settings.
AuthorsO'Brien, D P
AffiliationAIDS Working Group, Médecins Sans Frontières, Paris, France. firstname.lastname@example.org
MetadataShow full item record
JournalClinical Infectious Diseases
AbstractA study of 568 children aged <5 years who commenced nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings revealed good early outcomes. After 12 months of antiretroviral therapy, survival probability was 0.89 (95% confidence interval, 0.86-0.92), with no significant difference among children stratified on the basis of baseline immunological levels; 62% attained a CD4 cell percentage >25%, and 7% continued to have a CD4 cell percentage <15%.
- Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
- Authors: Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A
- Issue date: 2008 Jul 11
- In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.
- Authors: O'Brien DP, Sauvageot D, Zachariah R, Humblet P, Medecins Sans Frontieres.
- Issue date: 2006 Oct 3
- Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.
- Authors: Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, Joffres M, Anema A, Cooper CL, Montaner JS, Mills EJ
- Issue date: 2008 Nov 30
- Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
- Authors: Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswani M, Gaur AH, Chadwick EG, Pediatric AIDS Clinical Trials Group P1030 Team.
- Issue date: 2007 May 15
- Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy.
- Authors: Rajendran PM, Dolev JC, Heaphy MR Jr, Maurer T
- Issue date: 2005 Oct